Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-021498
Filing Date
2016-07-26
Accepted
2016-07-26 16:01:05
Documents
39
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aldr-10q_20160630.htm 10-Q 1567322
2 EX-31.1 aldr-ex311_7.htm EX-31.1 15514
3 EX-31.2 aldr-ex312_6.htm EX-31.2 15511
4 EX-32.1 aldr-ex321_8.htm EX-32.1 8664
  Complete submission text file 0001564590-16-021498.txt   4143254

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldr-20160630.xml EX-101.INS 868955
6 XBRL TAXONOMY EXTENSION SCHEMA aldr-20160630.xsd EX-101.SCH 21479
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldr-20160630_cal.xml EX-101.CAL 34190
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldr-20160630_def.xml EX-101.DEF 36839
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldr-20160630_lab.xml EX-101.LAB 159848
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldr-20160630_pre.xml EX-101.PRE 114597
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36431 | Film No.: 161784423
SIC: 2834 Pharmaceutical Preparations